Category Archives: Health

Latest From Health

Emerging Themes in Personalized Medicine

1500x500

The adoption of Personalized Medicine is being driven by the omnipresence of Next-Generation Sequencing (NGS), the fast pace of technological innovations in the field, and the President’s Precision Medicine Initiative. To date, however, only a relatively small fraction of the patient population has had their DNA fully sequenced, while a larger segment has undergone limited analysis related to an NGS-based diagnostics test, primarily in the area of oncology. It is expected that this picture will Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

WSJ Article Cherry Picks Cost, Ignores Value of Medicines

Jim Greenwood

Today’s Wall Street Journal story, “Price Increases Drive Drug Firms’ Revenue” reaffirms that old chestnut, “…a little information is a dangerous thing…”  When speaking to the complexities of the costs and benefits of America’s healthcare system, a publication like the Wall Street Journal should not cherry pick one aspect of that system to cover while ignoring the rest. Unfortunately and uncharacteristically, in this case, the paper focused on particular costs while ignoring value. In fact, Read More >

Health  |  1 Comment  |  Email This Post
Tags: ,

Biopharma Companies Fight Tropical Diseases to Improve Global Health

International

Neglected tropical diseases (NTDs) are a group of devastating viral, bacterial, and parasitic diseases that predominantly burden individuals and communities living in poverty. NTDs received the moniker “neglected” due to the lack of attention they have received from the global biopharmaceutical community, and the resultant dearth of products available to prevent, diagnose, and treat them. This has been changing, though – Knight Therapeutics Inc. developed a drug to treat leishmaniasis (Impavido®) in 2014, Sanofi Pasteur Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

Dr. Scott Gottlieb: A Clintonian Misdirection on Drug Prices

Hillary Clinton

Today’s Wall Street Journal contains an excellent op-ed by Dr. Scott Gottlieb, a physician and resident fellow at the American Enterprise Institute. Dr. Gottlieb takes aim at the recent proposal offered by the campaign of Secretary Hillary Clinton to aggressively regulate the price of innovative prescription medicines. BIO shared many of those concerns in our statement and a related blog post. Dr. Gottlieb notes, “It’s important to distinguish between new medicines that are priced at Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

Discover Trends and Investment Opportunities at the BIO Investor Forum

hyde pier

The 2015 BIO Investor Forum in San Francisco is shaping up to be a must-attend event for private equity and public investors, research analysts, and industry executives focused on investment and business development opportunities in the life sciences. The Forum will include candid fireside chats between biopharma CEOs, analysts, and other industry experts. Come hear about recent company successes, what keeps the C-suite up at night, and where the industry’s leading companies are headed in 2016. Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,